Braf and erbB2 Mutations Correlate With Smoking Status in Lung Cancer Patients

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2012.500
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

P1.13-45 Coexistence of Activating BRAF and KRAS Mutations in Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.03-12 EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Brief Report: EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

EGFR Mutations Status for Non-Small-Cell Lung Cancer Patients

Sveikatos mokslai
2016English

P3.03-01 BRAF V600 and Non-V600 Mutations in Chinese Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Molecular Pathological Epidemiology of Colorectal Cancer in Chinese Patients With KRAS and BRAF Mutations

Oncotarget
Oncology
2015English

P2.13-46 Comprehensive Investigation of ERBB2 Transmembrane Domain Mutations (V659/G660) in 12,833 Chinese Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer

JAMA Surgery
Surgery
2018English

Editorial: Smoking Status and 5-Year Survival in Patients With Colorectal Cancer

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy